The pharma industry as a whole has behaved similarly, cranking up political contributions and lobbying. Meanwhile, despite much talk about change, Congress and the Trump administration have done little to control drug prices or threaten drug-company profits. Jay Hancock, Kaiser Health News and Elizabeth Lucas, […]
“My whole life has been rearranged around trying to get health insurance,” Garnett Mellen, 56, said, as she explained that claiming residency with her daughter in the new ZIP code had cut their premiums by more than half. Rachel Bluth, Kaiser Health News CHARLOTTESVILLE, Va. […]
Introducing Jeanne Ertle, our latest unsung hero of healthcare reform! This project of HEAL California, highlights the hard work and dedication of individuals who are working – often in the background – to win Medicare-for-All in California and the nation. The end goal for Jeanne […]
The Attorney General’s refusal signals his agreement with health consumer advocates, who argue that patients still are struggling to pay their bills, even when they have insurance. Advocates say it shows he understands there are still “unmet needs” for financial assistance for people who have high-deductible […]
Meet Daniel Hilsinger, our newest unsung hero of healthcare reform! This project of HEAL California, highlights the hard work and dedication of individuals who are working – often in the background – to win Medicare-for-All in California and the nation. Daniel Hilsinger‘s healthcare awakening began […]
The story of Korlym highlights how America’s drug development system can turn an old drug into a new one that treats relatively few — but often very desperate — patients. Sarah Jane Tribble, Kaiser Health News Even though the $550 yellow pills sold as Korlym have […]
Since 2013, the numbers of Americans supporting or opposing universal healthcare have gradually flipped themselves, and now polls over that time consistently show that a majority want universal healthcare. When will leaders listen? This most recent was a March Kaiser Family Foundation poll that asked […]
Pharmaceutical companies are using their savings from recent corporate tax cuts to buy back shares of their own stock, enriching executives and wealthy investors as prescription drug prices continue to skyrocket, says Robert Reich, former Secretary of Labor. “It’s a two part scam,” he said. […]
